investor login

contact

team

dedicated funds

news

 portfolio

Cardiosense is building a physiological waveform data platform that leverages novel multi-modal sensors and industry-leading AI to develop predictive biomarkers for pre-symptomatic disease detection and enable personalized therapy.

VISIT WEBSITE

 

 

HVP VII, Med Tech

back to portfolio

contact

© hatteras venture partners | all rights reserved | terms + privacy | site credit

 team

 portfolio

news

home

Hatteras Venture Partners is a venture capital firm that builds transformational companies in areas of health innovation.

dedicated funds

contact

 team

dedicated funds

news

home

 portfolio